搜尋結果
FTC Warns ‘Junk Patents’ Could Make Drugs Like Ozempic Pricier—Here’s How
Forbes· 5 日前The Federal Trade Commission is challenging hundreds of alleged “junk” patent listings filed by ...
Marijuana backers eye proposed federal regulatory change as an aid to legalizing pot in more states
Bastillepost· 1 日前As the U.S. government moves toward reclassifying marijuana as a less dangerous drug, there may ...
Why Eli Lilly's earnings are no sure thing for traders despite obesity drug momentum
CNBC· 6 日前Eli Lilly appears to be making as much of its popular obesity and diabetes medicines as it can, ...
Canadian Pharmacy London Drugs Shuts Stores After Cyber Incident
Bloomberg· 6 日前Pharmacy chain London Drugs Ltd. shut dozens of stores in western Canada and even took down its ...
Oh, Canada: U.S. Patients Don't Want Your Health Policies
Forbes· 6 日前There's never been a worse time to get sick in Canada. The Canadian government has chosen ...
Real. Trial. Lawyers. Launch New Firm — SCHONBUCH HALLISSY LLP to Open Brentwood Office
Bastillepost· 4 日前The U.S. Drug Enforcement Administration is moving toward reclassifying marijuana as a less ...
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
CNBC· 3 日前Net profit rose 28% year-on-year to 25.4 billion Danish kroner ($3.65 billion), versus analyst ...
Here Are the Obesity Drug Hopefuls Vying to Unseat Ozempic, Zepbound
Bloomberg· 2 日前Insatiable demand for weight-loss drugs has made the market so feverish that any positive ...
Amgen 'encouraged' by weight-loss drug interim data, shares jump
Reuters· 3 日前, opens new tab on Thursday said it was very encouraged after completing an interim analysis of ...
Cannabis Stocks Spike Following Reports Marijuana Will Be Reclassified As Less Dangerous Drug
Forbes· 5 日前Cannabis company stocks skyrocketed Tuesday following multiple reports marijuana will be ...